180 related articles for article (PubMed ID: 2211570)
1. Buspirone in the management of major depression: a placebo-controlled comparison.
Fabre LF
J Clin Psychiatry; 1990 Sep; 51 Suppl():55-61. PubMed ID: 2211570
[TBL] [Abstract][Full Text] [Related]
2. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
Sramek JJ; Tansman M; Suri A; Hornig-Rohan M; Amsterdam JD; Stahl SM; Weisler RH; Cutler NR
J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
[TBL] [Abstract][Full Text] [Related]
4. Buspirone in depressed outpatients: a controlled study.
Rickels K; Amsterdam J; Clary C; Hassman J; London J; Puzzuoli G; Schweizer E
Psychopharmacol Bull; 1990; 26(2):163-7. PubMed ID: 2236452
[TBL] [Abstract][Full Text] [Related]
5. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
Feiger AD; Heiser JF; Shrivastava RK; Weiss KJ; Smith WT; Sitsen JM; Gibertini M
J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264
[TBL] [Abstract][Full Text] [Related]
6. Buspirone in major depression: a controlled study.
Rickels K; Amsterdam JD; Clary C; Puzzuoli G; Schweizer E
J Clin Psychiatry; 1991 Jan; 52(1):34-8. PubMed ID: 1988416
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam.
Strand M; Hetta J; Rosen A; Sörensen S; Malmström R; Fabian C; Marits K; Vetterskog K; Liljestrand AG; Hegen C
J Clin Psychiatry; 1990 Sep; 51 Suppl():40-5. PubMed ID: 2211567
[TBL] [Abstract][Full Text] [Related]
8. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
[TBL] [Abstract][Full Text] [Related]
9. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
Lee ST; Park JH; Kim M
Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
[TBL] [Abstract][Full Text] [Related]
13. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
[TBL] [Abstract][Full Text] [Related]
14. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Bremner JD
J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
[TBL] [Abstract][Full Text] [Related]
17. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia.
Mendels J; Kiev A; Fabre LF
Depress Anxiety; 1999; 9(2):54-60. PubMed ID: 10207659
[TBL] [Abstract][Full Text] [Related]
18. Estazolam treatment of insomnia in generalized anxiety disorder: a placebo-controlled study.
Post GL; Patrick RO; Crowder JE; Houston J; Ferguson JM; Bielski RJ; Bailey L; Pearlman HG; Shu VS; Pierce MW
J Clin Psychopharmacol; 1991 Aug; 11(4):249-53. PubMed ID: 1918423
[TBL] [Abstract][Full Text] [Related]
19. Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial.
Rickels K; Mathew S; Banov MD; Zimbroff DL; Oshana S; Parsons EC; Donahue SR; Kauffman M; Iyer GR; Reinhard JF
J Clin Psychopharmacol; 2008 Apr; 28(2):235-9. PubMed ID: 18344738
[TBL] [Abstract][Full Text] [Related]
20. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Schweizer E; Feighner J; Mandos LA; Rickels K
J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
